Paul L Nguyen Selected Research

Androgens

1/2022	The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
10/2021	Optimizing androgen deprivation therapy with radiation therapy for aggressive localized and locally advanced prostate cancer.
10/2021	Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
1/2021	Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancer.
1/2021	Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
1/2021	Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
1/2021	Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.
12/2020	Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.
11/2020	Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96.
10/2020	Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul L Nguyen Research Topics

Disease

219	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 06/2004
103	Neoplasms (Cancer) 01/2022 - 10/2007
26	Neoplasm Metastasis (Metastasis) 10/2022 - 05/2008
7	Adenocarcinoma 10/2021 - 06/2012
7	Margins of Excision 01/2020 - 09/2011
7	Breast Neoplasms (Breast Cancer) 05/2014 - 05/2008
6	Carcinoma (Carcinomatosis) 01/2019 - 05/2005
5	Heart Failure 09/2015 - 01/2011
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 12/2015
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 07/2011
3	Erectile Dysfunction 10/2022 - 07/2012
3	COVID-19 01/2021 - 10/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 06/2012
3	Gynecomastia 01/2018 - 07/2012
3	Myocardial Infarction 09/2015 - 01/2011
2	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 03/2013
2	Dementia (Dementias) 01/2021 - 01/2020
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 10/2012
2	Fatigue 12/2018 - 08/2015
2	Hot Flashes 01/2018 - 05/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 05/2015
2	Urethral Stricture 12/2017 - 04/2014
2	Venous Thromboembolism 04/2016 - 06/2012
2	Peripheral Arterial Disease 04/2016 - 06/2012
2	Urinary Incontinence 01/2016 - 10/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015 - 01/2011
2	Lymphatic Metastasis 03/2015 - 05/2009
2	Rectal Neoplasms (Rectal Cancer) 09/2014 - 01/2013
2	Rectal Fistula (Anal Fistula) 09/2014 - 01/2013
2	Fistula 10/2007 - 10/2007

Drug/Important Bio-Agent (IBA)

75	AndrogensIBA 01/2022 - 03/2009
52	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 06/2004
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2011
8	Biological ProductsIBA 01/2021 - 05/2010
7	Hormones (Hormone)IBA 01/2021 - 06/2004
5	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2017
5	Phenobarbital (Luminal)FDA Link 01/2019 - 05/2008
4	Protons (Proton)IBA 01/2020 - 09/2007
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 06/2012
3	Docetaxel (Taxotere)FDA Link 10/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2015
3	HydrogelsIBA 09/2014 - 01/2013
3	Estrogen ReceptorsIBA 03/2012 - 05/2008
3	Progesterone Receptors (Progesterone Receptor)IBA 03/2012 - 05/2008
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 09/2010 - 12/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 03/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2018
2	Androgen Antagonists (Antiandrogens)IBA 01/2020 - 07/2012
2	A 17 (A-17)IBA 01/2020 - 10/2007
2	Tamoxifen FDA LinkGeneric 01/2019 - 05/2015
2	bicalutamide (Casodex)FDA LinkGeneric 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2015 - 05/2015
2	Tyrosine Kinase InhibitorsIBA 08/2015 - 05/2015
2	LipidsIBA 04/2015 - 01/2013
2	Testosterone (Sustanon)FDA Link 04/2014 - 11/2012
1	Interleukin-23 (Interleukin 23)IBA 10/2022
1	Interleukin-13IBA 10/2022
1	InterferonsIBA 10/2022
1	Interleukin-2 (IL2)IBA 10/2022
1	Interleukin-10 (Interleukin 10)IBA 10/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	CytokinesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	GenieIBA 11/2021
1	apalutamideIBA 10/2021
1	enzalutamideIBA 10/2021
1	Prednisolone (Predate)FDA LinkGeneric 10/2021
1	abirateroneIBA 10/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021

Therapy/Procedure

130	Therapeutics 01/2022 - 08/2007
111	Radiotherapy 10/2022 - 06/2004
66	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 10/2007
48	Brachytherapy 03/2021 - 10/2007
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2012
7	Castration 10/2021 - 04/2016
6	Proton Therapy 11/2017 - 10/2007
5	Salvage Therapy 01/2021 - 03/2005
5	Cystectomy 01/2021 - 12/2015
5	Orchiectomy (Orchidectomy) 04/2016 - 06/2012
4	Lymph Node Excision (Lymph Node Dissection) 12/2015 - 02/2011
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2016
3	Aftercare (After-Treatment) 01/2020 - 11/2010
3	Cryosurgery 11/2018 - 10/2007
3	Nephrectomy 01/2016 - 07/2011
3	Adjuvant Radiotherapy 04/2014 - 10/2012
2	Conservative Treatment 10/2019 - 12/2017
2	Operative Surgical Procedures 01/2018 - 12/2015
2	Duration of Therapy 10/2017 - 08/2015
2	Re-Irradiation 04/2017 - 12/2013
2	Length of Stay 12/2015 - 05/2014
2	Terminal Care (Care, Terminal) 09/2015 - 02/2015
2	Cryotherapy (Therapy, Cold) 12/2014 - 07/2012
2	Colostomy 09/2014 - 10/2007
2	Operative Time 05/2014 - 09/2011
2	Segmental Mastectomy (Lumpectomy) 05/2010 - 05/2008
1	Radioimmunotherapy 01/2022
1	Treatment Delay 01/2022